Comparison of the commercial quantiFERON-CMV and overlapping peptide-based ELISPOT assays for predicting CMV infection in kidney transplant recipients

Immune Network

Volumn 17, Issue 5, 2017, Pages 317-325

  Kwon, Ji Soo ^a,b   Kim, Taeeun ^b   Kim, Sun Mi ^b   Sung, Heungsup ^b   Shin, Sung ^b   Kim, Young Hoon ^b   Shin, Eui Cheol ^a   Kim, Sung Han ^b   Han, Duck Jong ^b  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Cell mediated Immunity; Cytomegalovirus; Enzyme linked immunospot assay; Interferon gamma Release Test

Indexed keywords

GAMMA INTERFERON; GANCICLOVIR; IMMEDIATE EARLY 1 PROTEIN; IMMEDIATE EARLY 2 PROTEIN; IMMEDIATE EARLY PROTEIN; PEPTIDE; PHOSPHOPROTEIN; PHOSPHOPROTEIN 65; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DECEASED DONOR; DEVICE COMPARISON; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; KIDNEY GRAFT; LUNG LAVAGE; MALE; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT DURATION;

EID: 85033237416     PISSN: 15982629     EISSN: 20926685     Source Type: Journal    
DOI: 10.4110/in.2017.17.5.317     Document Type: Article

References (20)

1. Kim SH, Lee HJ, Kim SM, Jung JH, Shin S, Kim YH, Sung H, Lee SO, Choi SH, Kim YS, et al. Diagnostic usefulness of cytomegalovirus (CMV)-specific T cell immunity in predicting CMV infection after kidney transplantation: a Pilot Proof-of-Concept Study. Infect Chemother 2015;47:105-110. PUBMED | CROSSREF
2. Kim T, Lee YM, Lee SO, Choi SH, Kim YS, Woo JH, Sung H, Jung JH, Shin S, Kim YH, et al. Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy. Korean J Intern Med 2016;31:961-970. PUBMED | CROSSREF
3. Han JS, Lee SJ, Park WK, Ko YW, Kim HO, Lee SY. A survey on the cytomegalovirus antibodies in blood donors and the diseased. Korean J Blood Transfus 1990;1:21-34.
4. Jung J, Lee HJ, Kim SM, Kang YA, Lee YS, Chong YP, Sung H, Lee SO, Choi SH, Kim YS, et al. Diagnostic usefulness of dynamic changes of CMV-specific T-cell responses in predicting CMV infections in HCT recipients. J Clin Virol 2017;87:5-11. PUBMED | CROSSREF
5. Lochmanova A, Lochman I, Tomaskova H, Marsalkova P, Raszka J, Mrazek J, Dedochova J, Martinek A, Brozmanova H, Grundmann M. Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation. Transplant Proc 2010;42:3574-3577. PUBMED | CROSSREF
6. Cantisán S, Lara R, Montejo M, Redel J, Rodríguez-Benot A, Gutiérrez-Aroca J, González-Padilla M, Bueno L, Rivero A, Solana R, et al. Pretransplant interferon-γ secretion by CMV-specific CD8+ T cells informs the risk of CMV replication after transplantation. Am J Transplant 2013;13:738-745. PUBMED | CROSSREF
7. Rittà M, Costa C, Sidoti F, Ballocco C, Ranghino A, Messina M, Biancone L, Cavallo R. Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients. New Microbiol 2015.38:329-335.PUBMED
8. Forner G, Saldan A, Mengoli C, Gussetti N, Palù G, Abate D. Cytomegalovirus (CMV) enzyme-linked immunosorbent spot assay but not CMV QuantiFERON assay is a novel biomarker to determine risk of congenital CMV infection in pregnant women. J Clin Microbiol 2016;54:2149-2154. PUBMED | CROSSREF
9. Saldan A, Forner G, Mengoli C, Gussetti N, Palù G, Abate D. Strong cell-mediated immune response to human cytomegalovirus is associated with increased risk of fetal infection in primarily infected pregnant women. Clin Infect Dis 2015;61:1228-1234. PUBMED | CROSSREF
10. Distler E, Schnürer E, Wagner E, von Auer C, Plachter B, Wehler D, Huber C, Kolbe K, Meyer RG, Herr W. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation. Biol Blood Marrow Transplant 2008;14:1417-1424. PUBMED | CROSSREF
11. Schachtner T, Stein M, Babel N, Reinke P. The loss of BKV-specific Immunity from pretransplantation to posttransplantation identifies kidney transplant recipients at increased risk of BKV replication. Am J Transplant 2015;15:2159-2169. PUBMED | CROSSREF
12. Snyder LD, Chan C, Kwon D, Yi JS, Martissa JA, Copeland CA, Osborne RJ, Sparks SD, Palmer SM, Weinhold KJ. Polyfunctional T-cell signatures to predict protection from cytomegalovirus after lung transplantation. Am J Respir Crit Care Med 2016;193:78-85. PUBMED | CROSSREF
13. Solano C, Muñoz I, Gutiérrez A, Farga A, Prósper F, García-Conde J, Navarro D, Gimeno C. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation. J Clin Microbiol 2001;39:3938-3941. PUBMED | CROSSREF
14. Chiereghin A, Gabrielli L, Zanfi C, Petrisli E, Lauro A, Piccirilli G, Baccolini F, Dazzi A, Cescon M, Morelli MC, et al. Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. Transplant Proc 2010;42:69-73. PUBMED | CROSSREF
15. Costa C, Astegiano S, Terlizzi ME, Sidoti F, Curtoni A, Solidoro P, Baldi S, Bergallo M, Cavallo R. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients. Transplant Proc 2011;43:1159-1161. PUBMED | CROSSREF
16. Abate D, Fiscon M, Saldan A, Cofano S, Mengoli C, Sgarabotto D, d'Agostino C, Barzon L, Cusinato R, Toscano G, et al. Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection. J Clin Microbiol 2012;50:1974-1980. PUBMED | CROSSREF
17. Patel M, Stefanidou M, Long CB, Fazzari MJ, Tesfa L, Del Rio M, Lamour J, Ricafort R, Madan RP, Herold BC. Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipients. Pediatr Transplant 2012;16:18-28. PUBMED | CROSSREF
18. Westall GP, Mifsud NA, Kotsimbos T. Linking CMV serostatus to episodes of CMV reactivation following lung transplantation by measuring CMV-specific CD8+ T-cell immunity. Am J Transplant 2008;8:1749-1754. PUBMED | CROSSREF
19. Lisboa LF, Kumar D, Wilson LE, Humar A. Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia. Transplantation 2012;93:195-200. PUBMED | CROSSREF
20. Kim SH, Lee SO, Park JB, Park IA, Park SJ, Yun SC, Jung JH, Kim YH, Kim SC, Choi SH, et al. A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. Am J Transplant 2011;11:1927-1935. PUBMED | CROSSREF